Abstract：【Objective】 To study the correlation between LncRNA AC007009.1 and clinical stages of non-small cell lung cancer (NSCLC). 【Methods】 A total of 150 cases of NSCLC patients in our hospital from October 2015 to April 2019 were selected as the research objects. The cut-off value (5.23) of LncRNA AC007009.1 was taken from the median of LncRNA AC007009.1 level (5.24±2.05). The patients were divided into LncRNA AC007009.1 high expression group (n=93) and LncRNA AC007009.1 low expression group (n=57), The clinicopathological characteristics (age, gender, clinical stage, distant metastasis, smoking history, drinking history, tumor size) of the two groups were analyzed, and the difference information was included in the logistic regression analysis to analyze the risk factors of LncRNA AC007009.1 high expression, and to clarify the relationship between the pathological characteristics of NSCLC and LncRNA AC007009.1high expression, and to clarify the relationship between the pathological characteristics of NSCLC and lncRNA AC007009.1.【Results】 The patients with age≥60 years, distant metastasis, clinical stage Ⅲ or Ⅳ, smoking in high expression group were significantly more than those in low expression group (P<0.05); there was no significant difference in gender, history of alcohol abuse, tumor size between the two groups (P>0.05). Logistic regression analysis showed that age ≥ 60 years old, no distant metastasis, clinical stage Ⅲ or Ⅳ, smoking history were risk factors for LncRNA AC007009.1overexpression. 【Conclusion】 LncRNA AC007009.1 is closely related to the age, clinical stage, distant metastasis and smoking history of NSCLC. It can be used as an important indicator for early evaluation of NSCLC and has high clinical application value.
任红敏, 秦文婧. LncRNA AC007009.1与非小细胞肺癌临床分期相关性研究[J]. 医学临床研究, 2021, 38(2): 266-268.
REN Hong-min, QIN Wen-jing. Study on the Correlation between LncRNA AC007009.1 and Clinical Staging of Non-small Cell Lung Cancer. JOURNAL OF CLINICAL RESEARCH, 2021, 38(2): 266-268.
2021, Vol. 38 
